KTOV News and Press, Kitov Pharma Ltd. From 06/21/20

Will These 5 Penny Stocks Hit Your List This Week? Penny stocks , like any other equities, are a popular topic among investors. Obviously, this year has been a bit different thanks to a massive stock market sell-off in March. This actually created a higher demand for penny stocks in my opin...

Does Your List Of Penny Stocks Include These Companies? Do you trade penny stocks every day? If you’re like most readers, you’ve probably already made several trades today. But like most, you’re on the hunt for the next big penny stock breakout. More and more people are ...

Top Penny Stocks Trending Higher This Week The stock market is flying high at the start of the short week. Not only are blue-chip stocks jumping but so are a number of penny stocks . Positive sentiment has been a driving force to this latest move. The expectation that the economy is expecte...

4 Penny Stocks Taking Aim At New Highs This Month The countdown has begun to June 2020. This morning we’ve already seen plenty of penny stocks release news and updates . But a few have shown a remarkable response in the stock market today. Meanwhile, the broader markets have made an ...

The FDA has accepted Kitov Pharma's (NASDAQ: KTOV ) Investigational New Drug application to conduct a Phase 1/2 clinical trial of NT219, a novel agent addressing treatment resistance in advanced cancer. More news on: Kitov Pharma Ltd, Healthcare stocks news, Stocks on the move, Read ...

Company to Evaluate NT219 as Monotherapy Treatment of Advanced Solid Tumors and in Combination with Cetuximab for Treatment of Recurrent or Metastatic Solid Tumors and Head and Neck Cancer in a Phase 1/2 Trial TEL AVIV, Israel, May 22, 2020 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (“K...

Are These 3 Penny Stocks Worth A Closer Look For Robinhood & WeBull Users? If there’s one thing you know from the stock market today it’s that volatility is king. What better place to see that on a daily basis than from penny stocks . These cheap stocks fly high within a mat...

Kitov Pharma Ltd. (NASDAQ: KTOV ) commences the U.S. commercial launch of Consensi (amlodipine and celecoxib), approved by the FDA in May 2018 for the simultaneous treatment of high blood pressure (hypertension) and osteoarthritis pain. More news on: Kitov Pharma Ltd, Healthcare stocks n...

TEL AVIV, Israel, May 20, 2020 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced the U.S. commercial launch of Consensi™,...

Company Expects to Initiate Phase 1/2 Trial of NT-219 as Monotherapy Treatment of Advanced Solid Tumors and in Combination with cetuximab for Treatment of Recurrent or Metastatic Solid Tumors and Head and Neck Cancer TEL AVIV, Israel, May 19, 2020 (GLOBE NEWSWIRE) -- K...